VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405
VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405
复制标题
DOI:
10.1128/aac.43.9.2161
复制
发表时间:
1999-09-01
影响因子:
4.9
通讯作者:
Courvalin, P
中科院分区:
文献类型:
--
作者:
Fines, M;Perichon, B;Courvalin, P
Enterococcus faecalis BR BM4405 was resistant to low levels of vancomycin (MIC, 16 mu g/ml) and was susceptible to teicoplanin (MIC, 0.5 mu g/ml). No PCR product was obtained when the total DNA of this clinical isolate was used as a template with primers specific for glycopeptide resistance genes vanA, vanB, vanC, and vanD. However, a 604-bp PCR fragment was obtained when V1 and V2 degenerate primers were used and total DNA was digested with HindIII as a template. The product was cloned and sequenced. The deduced amino acid sequence had greater identity (55%) with VanC than with VanA (45%), VanB (43%), or VanD (44%). This was consistent with the fact that BM4405 synthesized peptidoglycan precursors that terminated in D-serine residues, after induction with vancomycin, weak D,D-dipeptidase and penicillin-insensitive D,D-carboxypeptidase activities were detected in cytoplasmic extracts of BM4405, whereas a serine racemase activity was found in the membrane preparation. This new type of acquired glycopeptide resistance was named VanE.